29 mai 2026
LSL PHARMA GROUP SECURES NEW STERI-MED COMMERCIAL AGREEMENTS EXPECTED TO GENERATE OVER $4 MILLION IN RECURRING ANNUAL REVENUES AND APPOINTS ALAIN R. DUGAL AS NEW EVP & COO
NEW STERI-MED COMMERCIAL AGREEMENTS & NEW EVP COO
NOUVELLES ENTENTES COMMERCIALES POUR STERI-MED & NOMINATION VPE & COO
26 mai 2026
LSL Pharma Group announces record revenues for Q1-26
